FDA inspection
Chengda Pharmaceuticals Co., Ltd.: FDA inspection ending Nov 20, 2020
FDA inspection 1135286 · No Action Indicated (NAI) · Jiashanxian
Key facts
| Inspection ID | 1135286 |
|---|---|
| Firm | Chengda Pharmaceuticals Co., Ltd. |
| FEI number | 3004248447 |
| Address | No. 36 Huangshe Road, Huimin Subdistrict, Jiashanxian |
| City | Jiashanxian |
| Fiscal year | 2021 |
| Inspection end date | Nov 20, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data